Start-Ups
MedTech Capital Matters May 2026
We present selected private financings for May, a month in that saw several $50 million-plus rounds for medical device companies.
Welcome to MyStrategist, the digital home for MedTech Strategist.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Start-Ups
Nephrodite Addresses Dialysis Pain Points With Implantable Solution
A kidney care start-up’s scaled-down dialysis device will offer patients newfound freedom from the tribulations of end-stage renal disease.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Regulatory & Reimbursement
In a Post-Inpatient Only Rule World, Tight ASC Margins, More Surgeon Choice
MS has eliminated all orthopedic procedures from the inpatient-only rule, as of January 1, 2026—part of a three-year plan to remove the list entirely--and is working on other policy changes that expand access to lower-cost ambulatory surgery centers. Experts highlight how these changes will affect manufacturers’ commercial strategies and influence ASC procurement in ways that both incentivize and discourage adoption of high-cost technologies.